Butyrate: A double-edged sword for health?

Advances in Nutrition

Volumn 9, Issue 1, 2018, Pages 21-29

  Liu, Hu ^a   Wang, Ji ^a   He, Ting ^a   Becker, Sage ^b   Zhang, Guolong ^b   Li, Defa ^a   Ma, Xi ^a,c  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Butyrate; G protein coupled receptors; Gut brain axis; Histone deacetylase; Inflammation; Intestinal barrier; Intestinal microbiota; Obesity

Indexed keywords

ANTIINFLAMMATORY AGENT; BUTYRIC ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GLYCOLIPID; HISTONE DEACETYLASE INHIBITOR;

COLON; DIETARY FIBER; DRUG EFFECT; ENERGY METABOLISM; FERMENTATION; HUMAN; IMMUNOLOGY; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE MUCOSA; METABOLISM; OBESITY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; BUTYRATES; COLON; DIETARY FIBER; ENERGY METABOLISM; FERMENTATION; GASTROINTESTINAL MICROBIOME; GLYCOLIPIDS; HISTONE DEACETYLASE INHIBITORS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 85041711241     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.1093/advances/nmx009     Document Type: Review

References (127)

1. Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extrainitestinal diseases.World J Gastroenterol 2011;17:1519-28
2. Fan P, Li L, Rezaei A, EslamfamS, Che D,Ma X.Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr Protein Pept Sci 2015;16:646-54
3. Ma N, Tian Y,Wu Y, Ma X. Contributions of the interaction between dietary protein and gut microbiota to intestinal health. Curr Protein Pept Sci 2017;18:795-808
4. Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obes Rev 2013;14:950-9
5. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. Fromthe gut to the peripheral tissues: themultiple effects of butyrate. Nutr Res Rev 2010;23:366-84
6. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013;5:1417-35
7. Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2014;7:17-44
8. Chen J, Li Y, Tian Y, Huang C, Li D, Zhong Q, Ma X. Interaction between microbes and host intestinal health: modulation by dietary nutrients and gut-brain-endocrine-immune axis.Curr Protein Pept Sci 2015;16:592-603
9. Jacobi SK, Odle J. Nutritional factors influencing intestinal health of the neonate. Adv Nutr 2012;3:687-96
10. de Clercq NC, Groen AK, Romijn JA, Nieuwdorp M. Gut microbiota in obesity and undernutrition. Adv Nutr 2016;7:1080-9
11. Tan J,McKenzie C, PotamitisM, Thorburn AN,Mackay CR,Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol 2014:91-119
12. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost F, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104-19
13. Hong J, Jia Y, Pan S, Jia L, Li H, Han Z, Cai D, Zhao R. Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice. Oncotarget 2016;7: 56071-82
14. Huang YP, Gao SX, Chen JL, Albrecht E, Zhao RQ, Yang XJ.Maternal butyrate supplementation induces insulin resistance associated with enhanced intramuscular fat deposition in the offspring. Oncotarget 2017;8:13073-84
15. Chen X, Eslamfam S, Fang L, Qiao S, Ma X. Maintenance of gastrointestinal glucose homeostasis by the gut-brain axis. Curr Protein Pept Sci 2017;18:541-7
16. van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen H, de Boer N, Welling G, Jansen PL. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 2005;11:865-71
17. Wang J, Han M, Zhang G, Qiao S, Li D, Ma X. The signal pathway of antibiotic alternatives on intestinal microbiota and immune function. Curr Protein Pept Sci 2016;17:785-96
18. Lagier JC,Hugon P,Khelaifia S, Fournier PE, La Scola B, Raoult D. The rebirth of culture inmicrobiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev 2015;28:237-64
19. Wilson M. The human microbiota: an historical perspective. In: Henderson B, Nibali L. (eds). The human microbiota and chronic disease: dysbiosis as a cause of human pathology. Hoboken (NJ): Academic Press; 2016, 3-36
20. Mokhtari Z, Gibson DL, Hekmatdoost A. Nonalcoholic fatty liver disease, the gut microbiome, and diet. Adv Nutr 2017;8:240-52
21. Haenen D, Zhang J, da Silva CS, Bosch G, van der Meer IM, van Arkel J, van den Borne JJ, Gutiérrez OP, Smidt H, Kemp B. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 2013;143:274-83
22. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017;19:29-41
23. Trachsel J, Bayles DO, Looft T, Levine UY, Allen HK. Function and phylogeny of bacterial butyryl coenzyme a: acetate transferases and their diversity in the proximal colon of swine. Appl EnvironMicrobiol 2016;82:6788-98
24. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta) genomic data. MBio 2014;5:e00889-14
25. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014;14:667-85
26. Byrne C, Chambers E, Morrison D, Frost G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int J Obes (Lond) 2015;39:1331-8
27. Kumar A, Alrefai WA, Borthakur A, Dudeja PK. Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2015;309:G602-7
28. Counillon L, Bouret Y, Marchiq I, Pouysségur J. Na+/H+ antiporter (NHE1) and lactate/H+ symporters (MCTs) in pH homeostasis and cancer metabolism. Biochim Biophys Acta 2016;1863:2465-80
29. Wang H, Yang C, Doherty JR, Roush WR, Cleveland JL, Bannister TD. Synthesis and structure-activity relationships of pteridine dione and trione monocarboxylate transporter 1 inhibitors. J Med Chem 2014;57:7317-24
30. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014;111: 2247-52
31. Schug ZT, Voorde JV, Gottlieb E. The metabolic fate of acetate in cancer. Nat Rev Cancer 2016;16:708-17
32. Plata C, Gavi-MazaM, Vázquez N, RomeroM, GambaG. Aspirin and salicylate are solutes of both sodium monocarboxylate transporters (SMCT1/Slc5a8 and SMCT2/Slc5a12)(896.9). FASEB J 2014;28(Suppl 1):896. 9
33. Singh V, Yang J, Chen T-e, Zachos NC, Kovbasnjuk O, Verkman AS, Donowitz M. Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption. Clin Gastroenterol Hepatol 2014;12:27-31
34. Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165:1332-45
35. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D,Muir AI,WigglesworthMJ,Kinghorn I, Fraser NJ, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003;278:11312-9
36. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014;156:84-96
37. Nohr MK, Egerod KL, Christiansen SH, Gille A, Offermanns S, Schwartz TW, Moller M. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience 2015;290:126-37
38. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014;20:159-66
39. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, Kobayashi M, Hirasawa A, Tsujimoto G. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci USA 2011;108: 8030-5
40. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 2013;4:1829
41. Voltolini C, Battersby S, Etherington SL, Petraglia F, Norman JE, Jabbour HN. A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 2012;153:395-403
42. Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Seier Poulsen S, Han S. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 2013;154:3552-64
43. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-73
44. Ingersoll SA, Ayyadurai S, CharaniaMA, Laroui H, Yan YT,Merlin D. The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.Am J Physiol Gastrointest Liver Physiol 2012;302:G484-92
45. Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, Maruya M, McKenzie CI, Hijikata A, Wong C. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 2015;6: 6734
46. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014;40:128-39
47. Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One 2011;6:10
48. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 2011;22:849-55
49. Wang W, Yang Q, Sun Z, Chen X, Yang C, Ma X. Advance of interactions between exogenous natural bioactive peptides and intestinal barrier and immune responses. Curr Protein Pept Sci 2015;16:574-5
50. Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, et al. Gpr109a is aG-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009;69:2826-32
51. Fu SP, Wang JF, Xue WJ, Liu HM, Liu BR, Zeng YL, Li SN, Huang BX, Lv QK, Wang W, et al. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms. J Neuroinflammation 2015;12:14
52. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009;325:834-40
53. Turner ND, Lupton JR. Dietary fiber. Adv Nutr 2011;2:151-2
54. Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gutmicrobiota in nutrition and health.Nat Rev GastroenterolHepatol 2012;9:577-89
55. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003;133(Suppl):2485S-93S
56. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 2012;48:612-26
57. Canani RB, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 2012;4:4
58. ParkJ,KimM, Kang SG, JannaschAH, Cooper B, PattersonJ,KimCH. Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 2015;8:80
59. SinghN, ThangarajuM, PrasadPD,MartinPM, LambertNA, Boettger T, Offermanns S,Ganapathy V. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J Biol Chem 2010;285:27601-8
60. Shi LZ, Wang RN, Huang GH, Vogel P, Neale G, Green DR, Chi HB. HIF1 alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of T(H)17 and T-reg cells. J ExpMed 2011;208:1367-76
61. Meijer K, de Vos P, Priebe MG. Butyrate and other short-chain fatty acids asmodulators of immunity:what relevance forhealth?CurrOpin Clin Nutr Metab Care 2010;13:715-21
62. Ma X, Fan P, Li L, Qiao S, Zhang G, Li D. Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions. J Anim Sci 2012;90:266-8
63. He L, Han M, Farrar S, Ma X. Impacts and regulation of dietary nutrients on gut microbiome and immunity. Protein Pept Lett 2017;24:380-1
64. Aguilar E, Leonel A, Teixeira L, Silva A, Silva J, Pelaez J, Capettini L, Lemos V, Santos R, Alvarez-Leite J. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation. Nutr Meta Cardiovasc Dis 2014;24:606-13
65. Venkatraman A, Ramakrishna B, Shaji R, Kumar NN, Pulimood A, Patra S. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-κB. Am J Physiol Gastrointest Liver Physiol 2003;285:G177-84
66. Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One 2012;7:e32841
67. Raso GM, Simeoli R, Russo R, Iacono A, Santoro A, Paciello O, Ferrante MC, Canani RB, Calignano A, Meli R. Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. PLoS One 2013;8:13
68. Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. PPARγ as a new therapeutic target in inflammatory bowel diseases. Gut 2006;55: 1341-9
69. Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schröder O. Involvement of different nuclear hormone receptors in butyratemediated inhibition of inducible NFκB signalling. Mol Immunol 2007;44:3625-32
70. Liu T, Li J, Liu Y,Xiao N, SuoH,Xie K, Yang C,Wu C. Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264. 7 cells. Inflammation 2012;35:1676-84
71. Huang C, Song P, Fan P, Hou C, Thacker P, Ma X. Dietary sodium butyrate decreases postweaning diarrhea by modulating intestinal permeability and changing the bacterial communities in weaned piglets. J Nutr 2015;145:2774-80
72. Ma N,Wu Y, Xie F, Du K,Wang Y, Shi L, Ji L, Liu T, Ma X. Dimethyl fumarate reduces the risk of mycotoxins via improving intestinal barrier and microbiota. Oncotarget 2017;8:44625-38
73. Elamin EE, Masclee AA, Dekker J, Pieters H-J, Jonkers DM. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J Nutr 2013;143:1872-81
74. Willemsen L, Koetsier M, Van Deventer S, Van Tol E. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut 2003;52:1442-7
75. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 2012;15:474-9
76. Matter K, Aijaz S, Tsapara A, BaldaMS.Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. CurrOpin Cell Biol 2005;17:453-8
77. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009;139:1619-25
78. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, Scheppach W, Melcher R, Agerberth B, Lührs H, Gudmundsson G. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003;52:735-41
79. Huang X, Li Z, Zhu L, Huang H, Hou L, Lin J. Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in a Caco-2 cell monolayer model. J Pediatr Gastroenterol Nutr 2014;59:264-9
80. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 2012;57:3126-35
81. Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, Troost FJ, Venema K, Brummer RJM. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2009;28: 88-93
82. VinoloMA, RodriguesHG, Hatanaka E, Hebeda CB, Farsky SH, Curi R. Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci 2009;117:331-8
83. BöckerU,NebeT,HerweckF,HoltL, PanjaA, JobinC, Rossol S, Sartor R, Singer M. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol 2003;131:53-60
84. Guo P, Li Y, Eslamfam S, Ding W, Ma X. Discovery of novel genes mediating glucose and lipid metabolisms. Curr Protein Pept Sci 2017;18:609-18
85. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013;288:25088-97
86. Larraufie P, Doré J, Lapaque N, Blottière HM. TLR ligands and butyrate increase Pyy expression through two distinct but interregulated pathways. Cell Microbiol 2017;19:e12648
87. Miletta MC, Petkovic V, Eble A, Ammann RA, Fluck CE, Mullis PE. Butyrate increases intracellular calcium levels and enhances growth hormone release from rat anterior pituitary cells via the G-proteincoupled receptors GPR41 and 43. PLoS One 2014;9:8
88. den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen AK, Reijngoud DJ, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPAR-dependent switch from lipogenesis to fat oxidation. Diabetes 2015;64:2398-408
89. da Silva BC, Vieira FD,Mourino JLP, Bolivar N, SeiffertWQ. Butyrate and propionate improve the growth performance of Litopenaeus vannamei. Aquacult Res 2016;47:612-23
90. Rios-Covian D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilan CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 2016;7:9
91. Gao ZG, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye JP. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009;58:1509-17
92. LinHV, Frassetto A, Kowalik EJ, Nawrocki AR, Lu MFM, Kosinski JR, Hubert JA, Szeto D, Yao XR, Forrest G, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012;7:9
93. Keim NL, Martin RJ. Dietary whole grain-microbiota interactions: insights into mechanisms for human health. Adv Nutr 2014;5:556-7
94. DeFronzo RA, Buse JB, Kim T, Burns C, Skare S, Baron A, Fineman M. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia 2016;59:1645-54
95. Rondas D, D'Hertog W, Overbergh L, Mathieu C. Glucagon-like peptide-1: modulator of β-cell dysfunction and death. Diabetes Obes Metab 2013;15(Suppl 3):185-92
96. Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature 2006;444:854
97. Psichas A, Sleeth M, Murphy K, Brooks L, Bewick G, Hanyaloglu A, Ghatei M, Bloom S, Frost G. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) 2015;39:424-9
98. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011;12:272-81
99. Puertollano E, Kolida S, Yaqoob P. Biological significance of shortchain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care 2014;17:139-44
100. Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N. Ghrelin, CCK, GLP-1, and PYY (3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev 2017;97:411-63
101. Frost GS, Walton GE, Swann JR, Psichas A, Costabile A, Johnson LP, Sponheimer M, Gibson GR, Barraclough TG. Impacts of plant-based foods in ancestral hominin diets on the metabolism and function of gut microbiota in vitro. MBio 2014;5:e00853-14
102. Kato SI, Sato K, Chida H, Roh SG, Ohwada S, Sato S, Guilloteau P, Katoh K. Effects of Na-butyrate supplementation in milk formula on plasma concentrations of GH and insulin, and on rumen papilla development in calves. J Endocrinol 2011;211:241-8
103. Zhang Y, Fang F, Goldstein JL, Brown MS, Zhao T-J. Reduced autophagy in livers of fasted, fat-depleted, ghrelin-deficient mice: reversal by growth hormone. Proc Natl Acad Sci USA 2015;112:1226-31
104. Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS. Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013;98:E1072-87
105. Schwiertz A, TarasD, Schafer K, Beijer S, BosNA,Donus C,Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010;18:190-5
106. Knudsen KEB. Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health. Adv Nutr 2015;6:206-13
107. Turnbaugh PJ, Ley RE,Mahowald MA,Magrini V,Mardis ER,Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31
108. den BestenG, Lange K,Havinga R, van Dijk TH,Gerding A, van Eunen K, Muller M, Groen AK, Hooiveld GJ, Bakker BM, et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 2013;305:G900-10
109. Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 2011;45:S120-S7
110. Gonçalves P, Martel F. Butyrate and colorectal cancer: the role of butyrate transport. Curr Drug Metab 2013;14:994-1008
111. Terova G, Díaz N, Rimoldi S, Ceccotti C, Gliozheni E, Piferrer F. Effects of sodium butyrate treatment on histonemodifications and the expression of genes related to epigenetic regulatory mechanisms and immune response in European sea bass (Dicentrarchus labrax) fed a plant-based diet. PLoS One 2016;11:e0160332
112. Birt DF, Boylston T, Hendrich S, Jane J-L, Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M. Resistant starch: promise for improving human health. Adv Nutr 2013;4:587-601
113. Wong DHJ, Beiko RG. Transfer of energy pathway genes in microbial enhanced biological phosphorus removal communities. BMC Genomics 2015;16:526
114. Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int 2016;99:110-32
115. Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013;167: 374-9
116. Chen X, D'Souza R, Hong S-T. The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell 2013;4:403-14
117. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701-12
118. Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl Res 2017;179:223-44
119. Ghaisas S, Maher J, Kanthasamy A. Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 2016;158:52-62
120. Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley E. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013;25:4-15
121. Soret R, Chevalier J, De Coppet P, Poupeau G, Derkinderen P, Segain JP, Neunlist M. Short-chain fatty acids regulate the enteric neurons and control gastrointestinalmotility in rats. Gastroenterology 2010;138:1772-82, e4
122. van de Wouw M, Schellekens H, Dinan TG, Cryan JF. Microbiotagut-brain axis: modulator of host metabolism and appetite. J Nutr 2017;147:727-45
123. Gagliano H, Delgado-Morales R, Sanz-Garcia A, Armario A. High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response. Neuropharmacology 2014;79:75-82
124. Castanys-Muñoz E, Martin MJ, Vazquez E. Building a beneficial microbiome from birth. Adv Nutr 2016;7:323-30
125. Selkrig J, Wong P, Zhang X, Pettersson S. Metabolic tinkering by the gutmicrobiome: Implications for brain development and function.Gut Microbes 2014;5:369-80
126. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour-epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014;13:69-86
127. Keenan MJ, Zhou J, Hegsted M, Pelkman C, DurhamHA, Coulon DB, Martin RJ. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr 2015;6:198-205